Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole

Gastrointestinal Endoscopy

Volumn 44, Issue 6, 1996, Pages 700-705

  Malesci, A ^a   Savarino, V ^a   Zentilin, P ^a   Belicchi, M ^a   Mela, G S ^a   Lapertosa, G ^a   Bocchia, P ^a   Ronchi, G ^a   Franceschi, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; OMEPRAZOLE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS PH; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; PRIORITY JOURNAL; REMISSION; STOMACH ACID SECRETION; STOMACH PH;

EID: 0030480397     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(96)70055-X     Document Type: Article

References (27)

1. SR. Hamilton Pathogenesis of columnar cell-lined (Barrett's) esophagus SJ Spechler RK Goyal Barrett's esophagus: pathophysiology, diagnosis and management. 1985 Elsevier Science New York 29 37
2. MB Fennerty RE Sampliner HS Garewal Barrett's oesophagus—cancer risk, biology and therapeutic management Aliment Pharmacol Ther 7 1993 339 345
3. J. Dent Approaches to oesophageal columnar metaplasia (Barrett's oesophagus) Scand J Gastroenterol 24 suppl 168 1989 60 66
4. SY Iftikhar PD James RJC Steele JD Hardcastle M. Atkinson Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma Gut 33 1992 1155 1158
5. RE Sampliner HS Garewal MB Fennerty M. Aickin Lack of impact of therapy on extent of Barrett's esophagus in 67 patients Dig Dis Sci 1 1990 93 96
6. WA Williamson FH Ellis Jr SP Gibbs DM Shuhian HT. Arotz Effect of antireflux operation on Barrett's mucosa Ann Thorac Surg 49 1990 537 542
7. J Deviere M Buset JM Dumocean F Richaert M. Cremer Regression of Barrett's epithelium with omeprazole N Engl J Med 320 1989 1497 1498
8. S Gore CJ Healey R Sutton IA Eyre-Brook MW Gear NA Shepherd Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy Aliment Pharmacol Ther 7 1993 623 628
9. RE. Sampliner Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus Am J Gastroenterol 89 1994 1844 1848
10. RH Riddell H Goldman DF Ransohoff HD Appleman CM Fenoglio RC Haggitt Dysplasia in inflammatory bowel disease. Standardized classification with provisional clinical applications Hum Pathol 14 1983 931 968
11. V Savarino GS Mela P Scalabrini MR Magnolia E Di Timoteo G Percario Continuous 24-hour intragastric pH monitoring: focus on reproducibility in duodenal ulcer patients Gastroenterol Clin Biol 10 1986 826 830
12. GS Mela V Savarino A Sumberaz G Bonifacino P Zentilin G Villa Continuous acidity monitoring in the study of gastric antisecretory drugs. pH or antilog transformation of pH, mean or median? Am J Gastroenterol 85 1990 1105 1108
13. GS Mela V Savarino S. Vigneri Optimizing the information obtained from continuous 24-hour gastric pH monitoring Am J Gastroenterol 87 1992 961 966
14. BI Hirschowitz J. Barton Gastric acid and pepsin secretion in patients with Barrett's esophagus (BES) [abstract] Gastroenterology 98 1990 A60
15. ICE Wesdorp J Bartelsman MEI. Schipper Effect of long-term treatment with cimetidine and antacid in Barrett's oesophagus Gut 22 1981 724 727
16. BT Cooper GO. Barbezat Treatment of Barrett's esophagus with H2 blockers J Clin Gastroenterol 9 1987 139 141
17. S Fiorucci L Santucci F Farroni MA Pelli A. Morelli Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus Am J Gastroenterol 84 1989 1263 1267
18. J Francis R Shaffer S Kadakia J. Carrougher Effect of omeprazole on Barrett's epithelium at 3 and 9 months of therapy [abstract] Gastroenterology 104 1993 A80
19. JP Galmiche R Dumas J Boyer D Goldfain A Bury M Robaszkiewicz Long-term omeprazole effects on Barrett's mucosa [abstract] Gastroenterology 104 1993 A85
20. V Savarino GS Mela P Zentilin P Cutela MR Mele S Vigneri Variability of individual response to various doses of omeprazole. Implications for ulcer therapy Dig Dis Sci 39 1994 161 168
21. S Vigneri V Savarino GS Mela R Termini F Di Mario M Pantalena A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer Scand J Gastroenterol 29 1994 488 492
22. CH Wilder-Smith T Ernst M Gennoni B Zeyen F Halter HS. Merki Tolerance to oral H2-receptor antagonists Dig Dis Sci 35 1991 976 983
23. W Londong V Londong C Cederberg H. Steffen Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release Gastroenterology 85 1983 1373 1378
24. G Brunner W Creutzfeldt U Harke R. Lamberts Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment Digestion 39 1988 80 90
25. G Champion JE Richter MF Vaezi S Singh R. Alexander Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus Gastroenterology 107 1994 747 754
26. EC Klinkenberg-Knol SGM. Meuwissen Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole Aliment Pharmacol Ther 4 1990 485 495
27. V Savarino GS Mela P Zentilin MR Mele S Vigneri C Mansi The effects of omeprazole 20 mg and 40 mg twice daily on intragastric acidity in duodenal ulcer patients Aliment Pharmacol Ther 1996 [in press]